News
Chan Zuckerberg Initiative to put $250M into new NYC Biohub
The Chan Zuckerberg Initiative is launching a new Biohub, its third, …
19795 items found
News
Evident Vascular raises $35m, and other digital financings
Our latest rundown of funding and financing rounds in the digital …
Oncology
Elements in precision oncology
Validating the regulatory expectations on evidential requirements for …
News
UCB bags FDA approval for second myasthenia gravis drug
Belgian biopharma UCB has been given the green light by the FDA for …
News
Seagen wins future royalties in Enhertu patent dispute
Daiichi Sankyo has been ordered to pay an 8% royalty rate on sales of …
News
Gilead plans European trial of twice-yearly HIV PrEP drug
Gilead Sciences has said it will soon start a clinical trial in …
News
Roche sticks with molecular glue, partnering Monte Rosa
Roche seems determined to develop a commanding position in the …
Market Access
Medical drone delivery set for global take off
Delivery by drone is often talked about in the retail sector – to …
News
Nucleus RadioPharma raises $56m in first round financing
There’s a new kid on the block in the fast-growing …
News
Roche builds gene therapy portfolio with SpliceBio deal
Roche’s gene therapy unit Spark has added to its pipeline in …
News
Owkin signs up another pharma partner for its AI platform
France’s Servier has become the latest pharma group to tap into an …
News
VR-based navigation test may detect Alzheimer’s
A virtual reality-based task could help differentiate people with …
R&D
From neurosurgery to focused ultrasound: Not if, but when
Therapeutic or focused ultrasound began being applied to neurologic conditions less than a decade ago, but its potential in a wide spectrum of brain applications is high.
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Sales & Marketing
Sponsored
Seeking a single source of truth: Standardisation of the dat...
Oskar Mӧbert, Vice President of OpenData at Veeva Systems, spoke with Ian Cornish, Associate Director of Data Platforms at Astellas, about the company’s decision to opt into Veeva’s OpenDat
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
EHS&S for Biopharma & Pharma Summit
Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
